z-logo
open-access-imgOpen Access
The role of endothelin-1 receptor antagonist bosentan in the treatment of pulmonary hypertension
Publication year - 2017
Publication title -
consilium medicum
Language(s) - English
Resource type - Journals
eISSN - 2542-2170
pISSN - 2075-1753
DOI - 10.26442/2075-1753_19.10.113-117
Subject(s) - bosentan , endothelin receptor antagonist , pulmonary hypertension , endothelin receptor , medicine , antagonist , receptor antagonist , cardiology , pharmacology , receptor

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom